{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:33:45Z","timestamp":1791977625325,"version":"4.4.0"},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,11,15]]},"DOI":"10.2169\/internalmedicine.2973-19","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T22:03:21Z","timestamp":1562709801000},"page":"3251-3253","source":"Crossref","is-referenced-by-count":2,"title":["Extreme Elevation of the Prothrombin Time-International Normalized Ratio due to a Probable Interaction between Warfarin and Flutamide"],"prefix":"10.2169","volume":"58","author":[{"given":"Yasunobu","family":"Konishi","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, Toyota Kosei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Toyota Kosei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimori","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Toyota Kosei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Toyota Kosei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Le AT, Hasson NK, Lum BL. Enhancement of warfarin response in a patient receiving etoposide and carboplatin chemotherapy. Ann Pharmacother 31: 1006-1008, 1997.","DOI":"10.1177\/106002809703100910"},{"key":"2","unstructured":"2. Copur MS, Ledakis P, Bolton M, et al. An adverse interaction between warfarin and: a case report and review of the literature. Clin Colorectal Cancer 1: 182-184, 2001."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Carabino J, Wang F. International normalized ratio fluctuation with warfarin - fluorouracil therapy. Am J Health Syst Pharm 59: 875, 2002.","DOI":"10.1093\/ajhp\/59.9.875"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Thompson ME, Highley MS. Interaction between paclitaxel and warfarin. Ann Oncol 14: 500, 2003.","DOI":"10.1093\/annonc\/mdg096"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Suzuki T, Koga H, Yamazaki S, et al. Probable interaction between warfarin and antitumor agents used in R-ESHAP chemotherapy. Clin Ther 30: 1155-1159, 2008.","DOI":"10.1016\/j.clinthera.2008.06.008"},{"key":"6","unstructured":"6. Takada N, Katagiri M, Nishii Y, et al. Drug interactions between warfarin and a combination of paclitaxel and carboplatin in a non-small cell lung cancer patient. Kitasato Med J 38: 59-62, 2008."},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Prandoni P, Lensing AWA, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100: 3484-3488, 2002.","DOI":"10.1182\/blood-2002-01-0108"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Akl EA, Kahale L, Barba M, et al. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst Rev 7: CD006650, 2014.","DOI":"10.1002\/14651858.CD006650.pub4"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285: 2370-2375, 2001.","DOI":"10.1001\/jama.285.18.2370"},{"key":"10","unstructured":"10. Asakawa N, Koyama M, Hashimoto Y, Yamashita K. Studies on the metabolic fate of Flutamide (1): plasma concentration after single administration of protein binding in rats. Yakubutsu Doutai 10: 447-453, 1995 (in Japanese, Abstract in English)."},{"key":"11","unstructured":"11. Heidbuchel H, Verhamme P, Alings M, et al. Updated European Heart Rhythm Association practical guide on the use of non-Vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J 38: 2137-2149, 2017."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Dickneite G. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation. Thromb Res 119: 643-651, 2007.","DOI":"10.1016\/j.thromres.2006.05.011"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/22\/58_2973-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T03:44:57Z","timestamp":1573875897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/22\/58_2973-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":12,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2973-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]}}}